Maravai Lifesciences Holdings (MRVI) Cash from Investing Activities (2020 - 2026)

Maravai Lifesciences Holdings' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$4.4 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 80.82% year-over-year to -$4.4 million; the TTM figure through Mar 2026 stood at -$12.7 million (up 70.57% YoY), while the FY2025 annual figure was -$31.4 million, down 29.15% from the prior year.
• Cash from Investing Activities was -$4.4 million for Q1 2026 at Maravai Lifesciences Holdings, down from -$2.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$1.7 million in Q2 2022 to a low of -$241.6 million in Q1 2022.
• Historically, Cash from Investing Activities has averaged -$26.5 million across 5 years, with a median of -$6.2 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities sank 8577.59% in 2022, then soared 93.91% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at -$18.5 million in 2022, then surged by 30.33% to -$12.9 million in 2023, then surged by 61.78% to -$4.9 million in 2024, then soared by 57.13% to -$2.1 million in 2025, then sank by 109.89% to -$4.4 million in 2026.
• The last three Cash from Investing Activities figures came in at -$4.4 million (Q1 2026), -$2.1 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.